Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
deals
3
×
life sciences
national blog main
national top stories
new york blog main
3
×
san francisco blog main
biotech
cancer
genentech
new york top stories
roche
san diego blog main
san diego top stories
san francisco
san francisco top stories
startups
accelerator
acetylon pharmaceuticals
airbnb
amazon web services (aws)
ambys medicines
artificial intelligence (a.i.)
athelas
atomwise
benchling
biotechnology
boston
cancer immunotherapy
cell therapy
center for medicare and medicaid services
coinbase
companion diagnostic
constellation pharmaceuticals
coworking
cruise
culture biosciences
daniel o'day
data analytics
What
big
3
×
startup
acquire
admits
ago
agreed
aiming
ambys
billion
biotech
biotechs
broad
classes
combinator
companies
confidence
control
deadly
deal
debuted
didn’t
diseases
dug
formed
foundation
future
gain
genentech
incubator
launch
life
liver
make
medicine
medicines
momentum
morning
new
panels
pay
Language
unset
Current search:
big
×
deals
×
" new york blog main "
×
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine